Preservation of intraalveolar surfactant in a rat lung ischaemia/reperfusion injury model

European Respiratory Journal

Volumn 15, Issue 3, 2000, Pages 526-531

  Ochs, M ^a   Fehrenbach, H ^b   Nenadic, I ^a   Bando, T ^c   Fehrenbach, A ^a,d   Schepelmann, D ^a   Albes, J M ^e   Wahlers, T ^d   Richter, J ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c KYOTO UNIVERSITY   (Japan)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Euro Collins solution; Ischaemia; Lung preservation; Reperfusion; Surfactant; Tubular myelin

Indexed keywords

LUNG SURFACTANT; MYELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; LUNG EDEMA; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; NONHUMAN; ORGAN PRESERVATION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; ULTRASTRUCTURE;

ANIMALS; PULMONARY ALVEOLI; PULMONARY SURFACTANTS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 0034059308     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.15.16.x     Document Type: Article

References (38)

1. Hawgood S. Surfactant: composition, structure, and metabolism. In: Crystal RG, West JB, Barnes PJ, Weibel ER, eds. The Lung: scientific foundations. 2nd Edn. Philadelphia, USA, Lippincott-Raven, 1997; pp. 557-571.
2. Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 1997; 77: 931-962.
3. Creuwels LAJM, van Golde LMG, Haagsman HP. The pulmonary surfactant system: biochemical and clinical aspects. Lung 1997; 175: 1-39.
4. Lewis JF, Novick RJ, Veldhuizen RAW. Surfactant in lung injury and lung transplantation. New York, USA, Springer-Verlag, 1997; pp. 1-181.
5. Hamm H, Kroegel C, Hohlfeld J. Surfactant: a review of its functions and relevance in adult respiratory disorders. Respir Med 1996; 90: 251-270.
6. Seeger W, Günther A, Walmrath HD. Alveolar surfactant and ARDS. In: Marini JJ, Evans TW, eds. Acute lung injury. Berlin, Germany, Springer-Verlag, 1998; pp. 88-106.
7. Jobe AJ, Ikegami M. Surfactant and acute lung injury. Proc Assoc Am Physicians 1998; 110: 489-495.
8. Klepetko W, Lohninger A, Wisser W, et al. Pulmonary surfactant in bronchoalveolar lavage after canine lung transplantation: effect of 1-carnitine application. J Thorac Cardiovasc Surg 1990; 99: 1048-1058.
9. Veldhuizen RAW, Lee J, Sandler D, et al. Alterations in pulmonary surfactant composition and activity after experimental lung transplantation. Am Rev Respir Dis 1993; 148: 208-215.
10. Erasmus ME, Petersen AH, Bambang Oetomo S, Prop J. The function of surfactant is impaired during the reimplant-ation response in rat lung transplants. J Heart Lung Transplant 1994; 13: 791-802.
11. Andrade RS, Solien EE, Wangensteen OD, Tsai MY, Kshettry VR, Bolman RM. Surfactant dysfunction in lung preservation. Transplantation 1995; 60: 536-541.
12. Casals C, Varela A, Ruano MLF, et al. Increase of C-reactive protein and decrease of surfactant protein A in surfactant after lung transplantation. Am J Respir Crit Care Med 1998; 157: 43-49.
13. Hohlfeld JM, Tiryaki E, Hamm H, et al. Pulmonary surfactant activity is impaired in lung transplant recipients. Am J Respir Crit Care Med 1998; 158: 706-712.
14. Veldhuizen RAW, McCaig LA, Akino T, Lewis JF. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995; 152: 1867-1871.
15. Fehrenbach H, Brasch F, Uhlig S, et al. Early alterations in intracellular and alveolar surfactant of the rat lung in response to endotoxin. Am J Respir Crit Care Med 1998; 157: 1630-1639.
16. Ochs M, Nenadic I, Fehrenbach A, et al. Ultrastructural alterations in intraalveolar surfactant subtypes after experimental ischemia and reperfusion. Am J Respir Crit Care Med 1999; 160: 718-724.
17. Maurer JR. The lung following transplantation. In: Crystal RG, West JB, Barnes PJ, Weibel ER, eds. The Lung: scientific foundations. 2nd edn., Philadelphia, USA, Lippincott Raven, 1997; pp. 2771-2785.
18. Trulock EP. Lung transplantation. Am J Respir Crit Care Med 1997; 155: 789-818.
19. Kirk AJB, Colquhoun IW, Dark JH. Lung preservation: a review of current clinical practice and future directions. Ann Thorac Surg 1993; 56: 990-1000.
20. Fukuse T, Albes JM, Takahashi Y, Brandes H, Hausen B, Schäfers HJ. Influence of red blood cells on lung function in an ex vivo heart-lung model. J Surg Res 1995; 59: 399-404.
21. Bando T, Albes JM, Fehrenbach H, Nüsse T, Schäfers HJ, Wahlers T. Influence of the potassium concentration on functional and structural preservation of the lung: where is the optimum? J Heart Lung Transplant 1998; 17: 715-724. (published erratum appeared in J Heart Lung Transplant 1998; 17: 1264).
22. Fehrenbach H, Schepelmann D, Albes JM, et al. Pulmonary ischemia/reperfusion injury: a quantitative study of structure and function in isolated heart-lungs of the rat. Anat Rec 1999; 255: 84-99.
23. Hopkinson DN, Bhabra MS, Hooper TL. Pulmonary graft preservation: a worldwide survey of current clinical practice. J Heart Lung Transplant 1998; 17: 525-531.
24. Fukuse T, Albes JM, Brandes H, Takahashi Y, Demertzis S, Schäfers HJ. Comparison of low potassium Euro-Collins solution and standard Euro-Collins solution in an extracorporeal rat heart-lung model. Eur J Cardiothorac Surg 1996; 10: 621-627.
25. Fehrenbach H, Ochs M. Studying lung ultrastructure. In: Uhlig S, Taylor AK, eds. Methods in pulmonary research. Basel, Switzerland, Birkhäuser, 1998; pp. 429-454.
26. Costabel U. Bronchoalveolar lavage: a standardized procedure or a technical dilemma? Eur Respir J 1991; 4: 776-777.
27. Baughman RP. The uncertainties of bronchoalveolar lavage. Eur Respir J 1997; 10: 1940-1942.
28. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 1999; 13: 1455-1476.
29. Wittwer T, Wahlers T, Fehrenbach A, et al. Combined use of prostacyclin and higher perfusate temperatures further enhances the superior lung preservation by Celsior solution in the isolated lung. J Heart Lung Transplant 1999; 18: 684-692.
30. Erasmus ME, Petersen AH, Haagsman HP, Bambang Oetomo S, Prop J. Surfactant treatment before reperfusion improves the immediate function of lung transplants in rats. Am J Respir Crit Care Med 1996; 153: 665-670.
31. Novick RJ, MacDonald J, Veldhuizen RAW, et al. Evaluation of surfactant treatment strategies after prolonged graft storage in lung transplantation. Am J Respir Crit Care Med 1996; 154: 98-104.
32. Hohlfeld JM, Strüber M, Ahlf K, et al. Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs. Eur Respir J 1999; 13: 1037-1043.
33. Heffner JE. Mechanisms underlying ischemia/reperfusion injury of the lung. In: Matthay MA, Ingbar DH, Eds. Pulmonary edema. Lung biology in health and disease, Vol. 116. New York, USA, Marcel Dekker, 1998; pp. 379-412.
34. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR, Matalon S. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol 1993; 265: L555-L564.
35. Putman E, van Golde LMG, Haagsman HP. Toxic oxidant species and their impact on the pulmonary surfactant system. Lung 1997; 175: 75-103.
36. Seeger W, Grube C, Günther A, Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 1993; 6: 971-977.
37. Pison U, Tam EK, Caughey GH, Hawgood S. Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastase. Biochim Biophys Acta 1989; 992: 251-257.
38. Baker CS, Evans TW, Randle BJ, Haslam PL. Damage to surfactant-specific protein in acute respiratory distress syndrome. Lancet 1999; 353: 1232-1237.